ABSTRACT
Dysregulation of the myeloid cell compartment is a feature of severe disease in hospitalized COVID-19 patients. Here, we investigated the response of circulating dendritic cell (DC) and monocyte subpopulations in SARS-CoV-2 infected outpatients with mild disease and compared it to the response of healthy individuals to yellow fever vaccine virus YF17D as a model of a well-coordinated response to viral infection. In SARS-CoV-2-infected outpatients circulating DCs were persistently reduced for several weeks whereas after YF17D vaccination DC numbers were decreased temporarily and rapidly replenished by increased proliferation until 14 days after vaccination. The majority of COVID-19 outpatients showed high expression of CD86 and PD-L1 in monocytes and DCs early on, resembling the dynamic after YF17D vaccination. In a subgroup of patients, low CD86 and high PD-L1 expression were detected in monocytes and DCs coinciding with symptoms, higher age, and lower lymphocyte counts. This phenotype was similar to that observed in severely ill COVID-19 patients, but less pronounced. Thus, prolonged reduction and dysregulated activation of blood DCs and monocytes were seen in a subgroup of symptomatic non-hospitalized COVID-19 patients while a transient coordinated activation was characteristic for the majority of patients with mild COVID-19 and the response to YF17D vaccination.
Subject(s)
COVID-19 , Yellow Fever , Humans , Monocytes , B7-H1 Antigen/metabolism , SARS-CoV-2 , Yellow fever virus , Vaccination , Dendritic CellsABSTRACT
Early in the course of infection, detection of pathogen-associated molecular patterns by innate immune receptors can shape the subsequent adaptive immune response. Here we investigate the influence of virus-associated innate immune activation on lymphocyte distribution in secondary lymphoid organs. We show for the first time that virus infection of mice induces rapid disruption of the Peyer's patches but not of other secondary lymphoid organs. The observed effect was not dependent on an active infectious process, but due to innate immune activation and could be mimicked by virus-associated molecular patterns such as the synthetic double-stranded RNA poly(I:C). Profound histomorphologic changes in Peyer's patches were associated with depletion of organ cellularity, most prominent among the B-cell subset. We demonstrate that the disruption is entirely dependent on type I interferon (IFN). At the cellular level, we show that virus-associated immune activation by IFN-α blocks B-cell trafficking to the Peyer's patches by downregulating expression of the homing molecule α4ß7-integrin. In summary, our data identify a mechanism that results in type I IFN-dependent rapid but reversible disruption of intestinal lymphoid organs during systemic viral immune activation. We propose that such rerouted lymphocyte trafficking may impact the development of B-cell immunity to systemic viral pathogens.
Subject(s)
Immunity, Innate/immunology , Peyer's Patches/immunology , Peyer's Patches/virology , Vesicular Stomatitis/immunology , Vesicular stomatitis Indiana virus/immunology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/immunology , B-Lymphocytes/virology , Cell Movement/immunology , Cells, Cultured , Female , Interferon Type I/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Peyer's Patches/pathology , RNA, Viral/immunology , Vesicular Stomatitis/pathology , Vesicular stomatitis Indiana virus/geneticsABSTRACT
BACKGROUND & AIMS: Helicobacter pylori infects half of the world's population, thereby causing significant human morbidity and mortality. The mechanisms by which professional antigen-presenting cells recognize the microbe are poorly understood. METHODS: Using dendritic cells (DCs) from TRIF, MyD88, TLR 2/4/7/9(-/-), and multiple double/triple/quadruple mutant mice, we characterized receptors and pathways mediating innate immune recognition of H pylori. RESULTS: We identified a MyD88-dependent component of the DC activation program, which was induced by surface TLRs, with TLR2 and to a minor extent also TLR4 being the exclusive surface receptors recognizing H pylori. A second MyD88-dependent component could be blocked in TLR2/4(-/-) DCs by inhibitors of endosomal acidification and depended on intracellular TLRs. We identified TLR9-mediated recognition of H pylori DNA as a principal H pylori-induced intracellular TLR pathway and further showed that H pylori RNA induces proinflammatory cytokines in a TLR-dependent manner. Microarray analysis showed complementary, redundant, and synergistic interactions between TLRs and additionally revealed gene expression patterns specific for individual TLRs, including a TLR2-dependent anti-inflammatory signature. A third component of the DC activation program was primarily composed of type I interferon-stimulated genes. This response was MyD88 and TRIF independent but was inducible by RIG-I-dependent recognition of H pylori RNA. CONCLUSIONS: These results provide novel comprehensive insights into the mechanisms of H pylori recognition by DCs. Understanding these processes provides a basis for the rational design of new vaccination strategies.
Subject(s)
Helicobacter pylori/immunology , Immunity, Innate/physiology , Receptors, Pattern Recognition/immunology , Signal Transduction/physiology , Animals , Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/metabolism , Cells, Cultured , DNA, Bacterial/metabolism , Dendritic Cells/immunology , Dendritic Cells/metabolism , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Gene Expression Profiling , Gene Expression Regulation , Helicobacter Infections/diagnosis , Helicobacter pylori/genetics , Immunity, Innate/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Models, Animal , RNA, Bacterial/metabolism , Receptors, Pattern Recognition/genetics , Receptors, Pattern Recognition/metabolism , Sensitivity and Specificity , Signal Transduction/genetics , Toll-Like Receptors/deficiencyABSTRACT
IFN regulatory factor 7 (IRF7) has been described as the master regulator of type I IFN responses and has been shown to be critical for innate antiviral immunity in vivo. In addition to type I IFN, NK cell responses are involved in the control of viral replication during acute viral infection. To investigate the role of IRF7 in the context of a viral infection that induces a strong NK cell response, the murine cytomegalovirus (MCMV) infection model was used. WT, IRF7-deficient and IRF3/IRF7-double deficient mice were infected with MCMV. The systemic IFN-alpha response to MCMV was entirely dependent on IRF7, but independent of IRF3. However, peak IFN-beta production during MCMV infection was not affected by the lack of IRF7 or both IRF7 and IRF3. Despite the complete lack of IFN-alpha production IRF7- and IRF3/IRF7-deficient mice were surprisingly efficient in controlling MCMV replication and were only modestly more susceptible to MCMV infection than WT mice. NK cell cytotoxicity was unimpaired and NK cell IFN-gamma production was enhanced in IRF7-deficient mice correlating with increased levels of bioactive IL-12. Owing to these compensatory mechanisms IRF7-dependent antiviral immune responses were not essential for resistance against acute MCMV infection in vivo.
Subject(s)
Dendritic Cells/immunology , Herpesviridae Infections/immunology , Interferon Regulatory Factor-3/metabolism , Interferon Regulatory Factor-7/metabolism , Killer Cells, Natural/immunology , Muromegalovirus/immunology , Animals , Cell Line , Cytotoxicity, Immunologic/immunology , Dendritic Cells/metabolism , Dendritic Cells/virology , Herpesviridae Infections/virology , Interferon Regulatory Factor-3/genetics , Interferon Regulatory Factor-3/immunology , Interferon Regulatory Factor-7/genetics , Interferon Regulatory Factor-7/immunology , Interferon-alpha/blood , Interferon-beta/blood , Interferon-gamma/blood , Interleukin-12/immunology , Interleukin-12/metabolism , Killer Cells, Natural/metabolism , Killer Cells, Natural/virology , Lymphocyte Activation/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Virus Replication/immunologyABSTRACT
Clinical observations in inflammatory bowel disease patients and experimental studies in rodents suggest that iron in the intestinal lumen derived from iron-rich food or oral iron supplementation could exacerbate inflammation and that iron depletion from the diet could be protective. To test the hypothesis that dietary iron reduction is protective against colitis development, the impact of iron reduction in the diet below 10 mg/kg on the course of CD4+ CD62L+ T cell transfer colitis was investigated in adult C57BL/6 mice. Weight loss as well as clinical and histological signs of inflammation were comparable between mice pretreated with semisynthetic diets with either < 10mg/kg iron content or supplemented with 180 mg/kg iron in the form of ferrous sulfate or hemin. Accumulation and activation of Ly6Chigh monocytes, changes in dendritic cell subset composition and induction of proinflammatory Th1/Th17 cells in the inflamed colon were not affected by the iron content of the diets. Thus, dietary iron reduction did not protect adult mice against severe intestinal inflammation in T cell transfer induced colitis.
Subject(s)
Dietary Supplements , Food, Formulated , Inflammatory Bowel Diseases , Iron/pharmacology , Th1 Cells , Th17 Cells , Adoptive Transfer , Animals , Colon/immunology , Colon/pathology , Dendritic Cells/immunology , Dendritic Cells/pathology , Disease Models, Animal , Inflammatory Bowel Diseases/diet therapy , Inflammatory Bowel Diseases/immunology , Inflammatory Bowel Diseases/pathology , Mice , Mice, Knockout , Monocytes/immunology , Monocytes/pathology , Th1 Cells/immunology , Th1 Cells/pathology , Th1 Cells/transplantation , Th17 Cells/immunology , Th17 Cells/pathology , Th17 Cells/transplantationABSTRACT
Pattern recognition receptors (PRRs) sensing commensal microorganisms in the intestine induce tightly controlled tonic signaling in the intestinal mucosa, which is required to maintain intestinal barrier integrity and immune homeostasis. At the same time, PRR signaling pathways rapidly trigger the innate immune defense against invasive pathogens in the intestine. Intestinal epithelial cells and mononuclear phagocytes in the intestine and the gut-associated lymphoid tissues are critically involved in sensing components of the microbiome and regulating immune responses in the intestine to sustain immune tolerance against harmless antigens and to prevent inflammation. These processes have been mostly investigated in the context of the bacterial components of the microbiome so far. The impact of viruses residing in the intestine and the virus sensors, which are activated by these enteric viruses, on intestinal homeostasis and inflammation is just beginning to be unraveled. In this review, we will summarize recent findings indicating an important role of the enteric virome for intestinal homeostasis as well as pathology when the immune system fails to control the enteric virome. We will provide an overview of the virus sensors and signaling pathways, operative in the intestine and the mononuclear phagocyte subsets, which can sense viruses and shape the intestinal immune response. We will discuss how these might interact with resident enteric viruses directly or in context with the bacterial microbiome to affect intestinal homeostasis.
Subject(s)
Gastrointestinal Microbiome/immunology , Homeostasis , Host-Pathogen Interactions/immunology , Immunity, Mucosal , Intestines/immunology , Intestines/virology , Animals , Biomarkers , Disease Susceptibility , Humans , Immunity, Innate , Inflammation , Intestinal Mucosa/metabolism , Phagocytes/immunology , Phagocytes/metabolism , Receptors, Pattern Recognition/genetics , Receptors, Pattern Recognition/metabolism , Signal TransductionABSTRACT
Dendritic cells which are located at the interface of innate and adaptive immunity are targets for infection by many different DNA and RNA viruses. Dendritic cell subpopulations express specific nucleic acid recognition receptors belonging to the Toll-like receptor family (TLR3, 7, 8, 9) and the cytosolic RNA helicase family (RIG-I, MDA5, LGP2). Activation of dendritic cells by viral DNA and RNA via these receptors is essential for triggering the innate antiviral immune response and shaping the ensuing adaptive antiviral immunity. This review will summarize our current knowledge of viral nucleic acid recognition and signaling by Toll-like receptors and RNA helicases focusing on recent evidence for their specific functions in antiviral defense in vivo.
Subject(s)
DNA, Viral/immunology , Dendritic Cells/metabolism , Immunity, Innate , RNA Helicases/metabolism , RNA, Viral/immunology , Toll-Like Receptors/metabolism , Viruses/immunology , Animals , DNA, Viral/metabolism , Dendritic Cells/immunology , Humans , Immunity, Active , RNA Helicases/immunology , RNA, Viral/metabolism , Toll-Like Receptors/immunologyABSTRACT
The immune system consists of specialized cell types with distinct functions in order to provide an effective innate and adaptive immune defense against harmful invading pathogens like bacteria, viruses, fungi, parasites, or other substances threatening the integrity of the organism. Once the immune system recognizes such pathogens via pattern recognition receptors (PRRs), they are taken up, processed, and presented as antigens on MHC class I and II to T lymphocytes by specialized cells called dendritic cells (DCs). At the same time pathogen components which bind to PRRs in DCs trigger potent cytokine and chemokine responses. Although other cell types like macrophages can also take up, process, and present antigens to naïve T lymphocytes, DCs are the cells with the greatest capacity to do so. Thus, DCs are also called professional antigen presenting cells (APCs), which induce a strong adaptive immune response and thereby act as a bridge between the innate and adaptive immune system. This chapter provides detailed instructions on how to generate various types of DCs from human peripheral blood mononuclear cells (PBMCs) and murine bone marrow, as well as stimulation conditions for activation of these cells by PRR ligands in vitro.
Subject(s)
Dendritic Cells/metabolism , Nucleic Acids/metabolism , Animals , Humans , Leukocytes, Mononuclear/metabolism , Receptors, Pattern Recognition/metabolism , Signal TransductionABSTRACT
The current view of cytoplasmic RNA-mediated innate immune signaling involves the differential activation of the RNA helicases retinoic acid-inducible gene 1 (RIG-I), melanoma differentiation-associated gene 5 (MDA5) and laboratory of genetics and physiology-2 (LGP2) by distinct RNA viruses. RIG-I, MDA5 and LGP2 form the RIG-I like receptor family (RLR). Since the initial characterization of the RLRs rapid progress has been made in the understanding of the molecular mechanisms that upon virus infection lead to the activation of downstream signaling cascades and the subsequent induction of type I interferon (IFN) and proinflammatory cytokines by these receptors. However, antiviral responses must be tightly regulated in order to prevent uncontrolled production of type I IFN that might have deleterious effects on the host. Exploring the structural and molecular mechanisms that underlie RLR signaling thus was accompanied by the discovery of how RLR-dependent antiviral responses are modulated. This article summarizes the current understanding of endogenous regulation in RLR signaling by various intrinsic molecules that exert their regulatory function in both the steady state or upon viral infection by targeting multiple steps of the signaling cascade.
Subject(s)
DEAD-box RNA Helicases/metabolism , Immunity, Innate , Membrane Proteins/metabolism , Nerve Tissue Proteins/metabolism , RNA Helicases/metabolism , Signal Transduction/immunology , Virus Diseases/metabolism , Viruses/metabolism , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/immunology , Adaptor Proteins, Signal Transducing/metabolism , Animals , Cell Communication , Cell Line , DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/immunology , Gene Expression/immunology , Host-Pathogen Interactions , Humans , Interferon Type I/biosynthesis , Interferon Type I/immunology , Interferon-Induced Helicase, IFIH1 , Membrane Proteins/genetics , Membrane Proteins/immunology , Mice , Mitochondria/genetics , Mitochondria/immunology , Mitochondria/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/immunology , RNA Helicases/genetics , RNA Helicases/immunology , Receptors, Cell Surface , Signal Transduction/genetics , Ubiquitination/immunology , Virus Diseases/immunology , Virus Diseases/virology , Virus Replication/physiology , Viruses/immunologyABSTRACT
The ATPase RIG-I senses viral RNAs that contain 5'-triphosphates in the cytoplasm. It initiates a signaling cascade that activates innate immune response by interferon and cytokine production, providing essential antiviral protection for the host. The mode of RNA 5'-triphosphate sensing by RIG-I remains elusive. We show that the C-terminal regulatory domain RD of RIG-I binds viral RNA in a 5'-triphosphate-dependent manner and activates the RIG-I ATPase by RNA-dependent dimerization. The crystal structure of RD reveals a zinc-binding domain that is structurally related to GDP/GTP exchange factors of Rab-like GTPases. The zinc coordination site is essential for RIG-I signaling and is also conserved in MDA5 and LGP2, suggesting related RD domains in all three enzymes. Structure-guided mutagenesis identifies a positively charged groove as likely 5'-triphosphate-binding site of RIG-I. This groove is distinct in MDA5 and LGP2, raising the possibility that RD confers ligand specificity.
Subject(s)
Adenosine Triphosphatases/metabolism , DEAD-box RNA Helicases/metabolism , Polyphosphates/metabolism , RNA Caps/metabolism , RNA, Viral/metabolism , Adenosine Triphosphatases/chemistry , Adenosine Triphosphatases/genetics , Adenosine Triphosphatases/immunology , Animals , Binding Sites/genetics , Cell Line , DEAD Box Protein 58 , DEAD-box RNA Helicases/chemistry , DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/immunology , Dimerization , Humans , Immunity, Innate/physiology , Interferon-Induced Helicase, IFIH1 , Interferons/genetics , Interferons/immunology , Interferons/metabolism , Polyphosphates/chemistry , Polyphosphates/immunology , Protein Structure, Tertiary/genetics , RNA Caps/chemistry , RNA Caps/genetics , RNA Caps/immunology , RNA Helicases/chemistry , RNA Helicases/genetics , RNA Helicases/immunology , RNA Helicases/metabolism , RNA, Viral/chemistry , RNA, Viral/genetics , RNA, Viral/immunology , Receptors, Immunologic , Structural Homology, Protein , Structure-Activity Relationship , Substrate Specificity/genetics , Zinc/chemistry , Zinc/immunology , Zinc/metabolism , rab GTP-Binding Proteins/chemistry , rab GTP-Binding Proteins/genetics , rab GTP-Binding Proteins/immunology , rab GTP-Binding Proteins/metabolismABSTRACT
The mammalian target of rapamycin (mTOR) can be viewed as cellular master complex scoring cellular vitality and stress. Whether mTOR controls also innate immune-defenses is currently unknown. Here we demonstrate that TLR activate mTOR via phosphoinositide 3-kinase/Akt. mTOR physically associates with the MyD88 scaffold protein to allow activation of interferon regulatory factor-5 and interferon regulatory factor-7, known as master transcription factors for pro-inflammatory cytokine- and type I IFN-genes. Unexpectedly, inactivation of mTOR did not prevent but increased lethality of endotoxin-mediated shock, which correlated with increased levels of IL-1beta. Mechanistically, mTOR suppresses caspase-1 activation, thus inhibits release of bioactive IL-1beta. We have identified mTOR as indispensable component of PRR signal pathways, which orchestrates the defense program of innate immune cells.